Vitamin D metabolism (WP1531)

Homo sapiens

Photochemical synthesis of vitamin D3 (cholecalciferol, D3) occurs cutaneously where pro-vitamin D3 (7-dehydrocholesterol) is converted to pre-vitamin D3 (pre-D3) in response to ultraviolet B (sunlight) exposure. DHCR7 encodes the enzyme 7-dehydrocholesterol (7-DHC) reductase, which converts 7-DHC to cholesterol, thereby removing the substrate from the synthetic pathway of vitamin D3, a precursor of 25-hydroxyvitamin D3.The finding that common variants at DHCR7 are strongly associated with circulating 25-hydroxyvitamin D concentrations suggests that this enzyme could have a larger role in regulation of vitamin D status than has previously been recognised. Vitamin D3, obtained from the isomerization of pre-vitamin D3 in the epidermal basal layers or intestinal absorption of natural and fortified foods and supplements, binds to vitamin D-binding protein (DBP) in the bloodstream, and is transported to the liver. D3 is hydroxylated by liver 25-hydroxylases (25-OHase). The resultant 25-hydroxycholecalciferol (25(OH)D3) is 1-hydroxylated in the kidney by 25-hydroxyvitamin D3-1 -hydroxylase (1-OHase). This yields the active secosteroid 1 ,25(OH)2D3 (calcitriol), which has different effects on various target tissues. The synthesis of 1,25(OH)2D3 from 25(OH)D3 is stimulated by parathyroid hormone (PTH) and suppressed by Ca2+, Pi and 1,25(OH)2D3 itself. The rate-limiting step in catabolism is the degradation of 25(OH)D3 and 1,25(OH)2D3 to 24,25(OH)D3 and 1,24,25(OH)2D3, respectively,which occurs through 24-hydroxylation by 25-hydroxyvitamin D 24-hydroxylase (24-OHase), encoded by the CYP24A1 gene. 24,25(OH)D3 and 1,24,25(OH)2D3 are consequently excreted. Vitamin D activity is mediated through binding of 1,25(OH)2D3 to the vitamin D receptor (VDR), which can regulate transcription of other genes involved in cell regulation, growth, and immunity. VDR modulates the expression of genes by forming a heterodimer complex with retinoid-X-receptors (RXR). Proteins on this pathway have targeted assays available via the [ CPTAC Assay Portal].


Chris Evelo , Lucia Ribeiro , Kristina Hanspers , Alex Pico , Martijn Van Iersel , Daniela Digles , Egon Willighagen , Martina Summer-Kutmon , Mingye Wang , Denise Slenter , and Eric Weitz


last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.


Homo sapiens


Micronutrients Renal Genomics Pathways


Cell Type Ontology

kidney cell skin fibroblast hepatocyte

Disease Ontology

rickets osteomalacia

Pathway Ontology

metabolic pathway of cofactors, vitamins, nutrients vitamin D metabolic pathway


Label Type Compact URI Comment
Inactive24,25-OH-vitamin D Metabolite hmdb:HMDB0000430
Calcidiol Metabolite hmdb:HMDB0003550
Calcidiol Metabolite hmdb:HMDB0003550
Previtamin D3 Metabolite chebi:8403
Calcitriol Metabolite hmdb:HMDB0001903
Pi Metabolite hmdb:HMDB0001429
Cholecalciferol Metabolite hmdb:HMDB0000876
Cholesterol Metabolite hmdb:HMDB0000067
7-Dehydro-cholesterol Metabolite hmdb:HMDB0000032
Ca Metabolite hmdb:HMDB0000464
RXRA GeneProduct ncbigene:6256
PTH GeneProduct ncbigene:5741
CYP2R1 GeneProduct ncbigene:120227
DHCR7 GeneProduct ncbigene:1717
CYP27A1 GeneProduct ncbigene:1593
Vitamin D binding protein GeneProduct ncbigene:2638
Alpha globulin GeneProduct :
RXRB GeneProduct ncbigene:6257
VDR GeneProduct ncbigene:7421
CYP24A1 GeneProduct ncbigene:1591
CYP27B1 GeneProduct ncbigene:1594
Vitamin D binding protein Protein uniprot:P02774


  1. Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Guo YD, Strugnell S, Back DW, Jones G. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8668–72. PubMed Europe PMC Scholia
  2. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Waterham HR, Wanders RJ. Biochim Biophys Acta. 2000 Dec 15;1529(1–3):340–56. PubMed Europe PMC Scholia
  3. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Proc Natl Acad Sci U S A. 2004 May 18;101(20):7711–5. PubMed Europe PMC Scholia
  4. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Norman AW. Am J Clin Nutr. 2008 Aug;88(2):491S-499S. PubMed Europe PMC Scholia
  5. Genome-wide association study of circulating vitamin D levels. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Hum Mol Genet. 2010 Jul 1;19(13):2739–45. PubMed Europe PMC Scholia
  6. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Lancet. 2010 Jul 17;376(9736):180–8. PubMed Europe PMC Scholia
  7. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. Genome Res. 2010 Oct;20(10):1352–60. PubMed Europe PMC Scholia